TotalMarketCap

Aprea Therapeutics

APRENasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$7.029 M

$0.50 -1.96%

Close of 6 Nov 2026

As of 6 Nov 2026, Aprea Therapeutics (APRE) has a market capitalization of $7.03M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$12.6M

Loss-making

Shares outstanding

14,191,136

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #432SoligenixSNGX$7.25M
  2. #433InMed PharmaceuticalsINM$7.14M
  3. #434Aprea TherapeuticsAPRE$7.03M
  4. #435Universe PharmaceuticalsUPC$6.98M
  5. #436MetaViaMTVA$6.92M

What if Aprea Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,989,754

Per share 4,017,271× higher

Bitcoin $1.53T

$107,662.14

Per share 217,368× higher

Apple $5.02T

$353,444.74

Per share 713,597× higher

Or at a round number

$10.0M$20.0M$50.0M$100.0M

Where these numbers come from

Share counts and financials for Aprea Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.